ROS1 fusion-positive non-small cell lung cancer-repotrectinib as a new treatment option

被引:0
作者
Rothschild, Sacha I. [1 ,2 ,3 ]
Mauti, Laetitia A. [4 ]
机构
[1] Cantonal Hosp Baden, Dept Oncol Hematol, Im Ergel 1, CH-5404 Baden, Switzerland
[2] Cantonal Hosp Baden, Canc Ctr, Im Ergel 1, CH-5404 Baden, Switzerland
[3] Univ Hosp Basel, Dept Med Oncol, Basel, Switzerland
[4] Cantonal Hosp Winterthur, Dept Oncol Hematol, Winterthur, Switzerland
关键词
non-small cell lung cancer (NSCLC); targeted therapy; repotrectinib; ANTITUMOR-ACTIVITY; REARRANGEMENTS; TALETRECTINIB; ENTRECTINIB; CRIZOTINIB; SAFETY;
D O I
10.21037/tcr-2025-263
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:3272 / 3276
页数:5
相关论文
共 25 条
[1]   ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers [J].
Bergethon, Kristin ;
Shaw, Alice T. ;
Ou, Sai-Hong Ignatius ;
Katayama, Ryohei ;
Lovly, Christine M. ;
McDonald, Nerina T. ;
Massion, Pierre P. ;
Siwak-Tapp, Christina ;
Gonzalez, Adriana ;
Fang, Rong ;
Mark, Eugene J. ;
Batten, Julie M. ;
Chen, Haiquan ;
Wilner, Keith D. ;
Kwak, Eunice L. ;
Clark, Jeffrey W. ;
Carbone, David P. ;
Ji, Hongbin ;
Engelman, Jeffrey A. ;
Mino-Kenudson, Mari ;
Pao, William ;
Iafrate, A. John .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (08) :863-870
[2]   Phase I/II ARROS-1 study of zidesamtinib (NVL-520) in ROS1 fusion-positive solid tumours [J].
Besse, B. ;
Drilon, A. E. ;
Cho, B. C. ;
Camidge, D. R. ;
Neal, J. ;
Lin, C-C. ;
Liu, S. V. ;
Nagasaka, M. ;
Kao, S. C-H. ;
Felip, E. ;
Van der Wekken, A. J. ;
Lin, C. C. ;
Bauman, J. R. ;
Gadgeel, S. ;
Samant, M. ;
Shen, J. ;
Sun, Y. ;
Zhu, V. W. ;
Upadhyay, V. A. ;
Lin, J. J. .
ANNALS OF ONCOLOGY, 2024, 35 :S804-S805
[3]   CHARACTERIZATION OF AN ACTIVATED HUMAN ROS GENE [J].
BIRCHMEIER, C ;
BIRNBAUM, D ;
WAITCHES, G ;
FASANO, O ;
WIGLER, M .
MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (09) :3109-3116
[4]   Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK) [J].
Cui, J. Jean ;
Tran-Dube, Michelle ;
Shen, Hong ;
Nambu, Mitchell ;
Kung, Pei-Pei ;
Pairish, Mason ;
Jia, Lei ;
Meng, Jerry ;
Funk, Lee ;
Botrous, Iriny ;
McTigue, Michele ;
Grodsky, Neil ;
Ryan, Kevin ;
Padrique, Ellen ;
Alton, Gordon ;
Timofeevski, Sergei ;
Yamazaki, Shinji ;
Li, Quhua ;
Zou, Helen ;
Christensen, James ;
Mroczkowski, Barbara ;
Bender, Steve ;
Kania, Robert S. ;
Edwards, Martin P. .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (18) :6342-6363
[5]   Molecular Analysis of Plasma From Patients With ROS1-Positive NSCLC [J].
Dagogo-Jack, Ibiayi ;
Rooney, Marguerite ;
Nagy, Rebecca J. ;
Lin, Jessica J. ;
Chin, Emily ;
Ferris, Lorin A. ;
Ackil, Jennifer ;
Lennerz, Jochen K. ;
Lanman, Richard B. ;
Gainor, Justin F. ;
Shaw, Alice T. .
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (05) :816-824
[6]   Computed Tomography Imaging Features and Distribution of Metastases in ROS1-rearranged Non-Small-cell Lung Cancer [J].
Digumarthy, Subba R. ;
Mendoza, Dexter P. ;
Lin, Jessica J. ;
Chen, Tianqi ;
Rooney, Marguerite M. ;
Chin, Emily ;
Sequist, Lecia, V ;
Lennerz, Jochen K. ;
Gainor, Justin F. ;
Shaw, Alice T. .
CLINICAL LUNG CANCER, 2020, 21 (02) :153-+
[7]   Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer [J].
Drilon, Alexander ;
Camidge, D. Ross ;
Lin, Jessica J. ;
Kim, Sang-We ;
Solomon, Benjamin J. ;
Dziadziuszko, Rafal ;
Besse, Benjamin ;
Goto, Koichi ;
de Langen, Adrianus Johannes ;
Wolf, Juergen ;
Lee, Ki Hyeong ;
Popat, Sanjay ;
Springfeld, Christoph ;
Nagasaka, Misako ;
Felip, Enriqueta ;
Yang, Nong ;
Velcheti, Vamsidhar ;
Lu, Shun ;
Kao, Steven ;
Dooms, Christophe ;
Krebs, Matthew G. ;
Yao, Wenxiu ;
Beg, Muhammad Shaalan ;
Hu, Xiufeng ;
Moro-Sibilot, Denis ;
Cheema, Parneet ;
Stopatschinskaja, Shanna ;
Mehta, Minal ;
Trone, Denise ;
Graber, Armin ;
Sims, Gregory ;
Yuan, Yong ;
Cho, Byoung Chul .
NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (02) :118-131
[8]   Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials [J].
Drilon, Alexander ;
Siena, Salvatore ;
Dziadziuszko, Rafal ;
Barlesi, Fabrice ;
Krebs, Matthew G. ;
Shaw, Alice T. ;
de Braud, Filippo ;
Rolfo, Christian ;
Ahn, Myung-Ju ;
Wolf, Juergen ;
Seto, Takashi ;
Cho, Byoung Chul ;
Patel, Manish R. ;
Chiu, Chao-Hua ;
John, Thomas ;
Goto, Koichi ;
Karapetis, Christos S. ;
Arkenau, Hendrick-Tobias ;
Kim, Sang-We ;
Ohe, Yuichiro ;
Li, Yu-Chung ;
Chae, Young K. ;
Chung, Christine H. ;
Otterson, Gregory A. ;
Murakami, Haruyasu ;
Lin, Chia-Chi ;
Tan, Daniel S. W. ;
Prenen, Hans ;
Riehl, Todd ;
Chow-Maneval, Edna ;
Simmons, Brian ;
Cui, Na ;
Johnson, Ann ;
Eng, Susan ;
Wilson, Timothy R. ;
Doebele, Robert C. .
LANCET ONCOLOGY, 2020, 21 (02) :261-270
[9]   Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibit ROS1/TRK/ALK Solvent-Front Mutations [J].
Drilon, Alexander ;
Ou, Sai-Hong Ignatius ;
Cho, Byoung Chul ;
Kim, Dong-Wan ;
Lees, Jeeyun ;
Lin, Jessica J. ;
Zhu, Viola W. ;
Ahns, Myung-Ju ;
Camidge, D. Ross ;
Nguyen, Judy ;
Zhai, Dayong ;
Deng, Wei ;
Huang, Zhongdong ;
Rogers, Evan ;
Liu, Juliet ;
Whitten, Jeff ;
Lim, John K. ;
Stopatschinskaja, Shanna ;
Hyman, David M. ;
Doebele, Robert C. ;
Cui, J. Jean ;
Shaw, Alice T. .
CANCER DISCOVERY, 2018, 8 (10) :1227-1236
[10]   Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1) [J].
Drilon, Alexander ;
Siena, Salvatore ;
Ou, Sai-Hong Ignatius ;
Patel, Manish ;
Ahn, Myung Ju ;
Lee, Jeeyun ;
Bauer, Todd M. ;
Farago, Anna F. ;
Wheler, Jennifer J. ;
Liu, Stephen V. ;
Doebele, Robert ;
Giannetta, Laura ;
Cerea, Giulio ;
Marrapese, Giovanna ;
Schirru, Michele ;
Amatu, Alessio ;
Bencardino, Katia ;
Palmeri, Laura ;
Sartore-Bianchi, Andrea ;
Vanzulli, Angelo ;
Cresta, Sara ;
Damian, Silvia ;
Duca, Matteo ;
Ardini, Elena ;
Li, Gang ;
Christiansen, Jason ;
Kowalski, Karey ;
Johnson, Ann D. ;
Patel, Rupal ;
Luo, David ;
Chow-Maneval, Edna ;
Hornby, Zachary ;
Multani, Pratik S. ;
Shaw, Alice T. ;
De Braud, Filippo G. .
CANCER DISCOVERY, 2017, 7 (04) :400-409